| Followers | 436 |
| Posts | 41282 |
| Boards Moderated | 0 |
| Alias Born | 10/07/2010 |
Saturday, January 18, 2020 8:11:03 AM
Not sure what all that related to - as my question was:
Quote:
GRN Funds is an investment firm established in 2014 by Justin Costello
Where was it established in 2014?
I provided links showing other lines of work notvquite matching up to that date of establishment.
Wasn’t it originally inc in Oregon?
http://records.sos.state.or.us/ORSOSWebDrawer/Recordpdf/4738450
United States flag GRN FUNDS, LLC (Washington (US), 18 Oct 2017- , 1000 2ND AVE STE 3900, SEATTLE, WA, 98104-3603)
United States flag GRN FUNDS, LLC (California (US), 21 Aug 2019- , 10866 WILSHIRE BLVD STE 225 LOS ANGELES CA 90024)
United States flag GRN FUNDS, LLC (Oregon (US), 10 Aug 2016- , 222 NW DAVIS ST STE 420, PORTLAND, OR, 97209)
Also I would like to know - since he made this claim on twitter:
When was he “in the war in IRAQ?”
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=151526929
“I guess you guys missed the due diligence when I was in the war in Iraq”
Or was that merely to add more legitimacy to his threat he was capable of beating that guy up?
And another missing piece of information - is he or was he ever married? Given he claimed to have a 10 year old son while campaigning and in another bio (Microcap advisors) claimed to be “a proud husband and father”
Did he make that up too? Was that claim to make him look more legitimate and stable?
There are just so many little (and not so little) discrepancies with his background it pretty tough to know what’s really true.
Quote:
GRN Funds is an investment firm established in 2014 by Justin Costello
Where was it established in 2014?
I provided links showing other lines of work notvquite matching up to that date of establishment.
Wasn’t it originally inc in Oregon?
http://records.sos.state.or.us/ORSOSWebDrawer/Recordpdf/4738450
United States flag GRN FUNDS, LLC (Washington (US), 18 Oct 2017- , 1000 2ND AVE STE 3900, SEATTLE, WA, 98104-3603)
United States flag GRN FUNDS, LLC (California (US), 21 Aug 2019- , 10866 WILSHIRE BLVD STE 225 LOS ANGELES CA 90024)
United States flag GRN FUNDS, LLC (Oregon (US), 10 Aug 2016- , 222 NW DAVIS ST STE 420, PORTLAND, OR, 97209)
Also I would like to know - since he made this claim on twitter:
When was he “in the war in IRAQ?”
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=151526929
“I guess you guys missed the due diligence when I was in the war in Iraq”
Or was that merely to add more legitimacy to his threat he was capable of beating that guy up?
And another missing piece of information - is he or was he ever married? Given he claimed to have a 10 year old son while campaigning and in another bio (Microcap advisors) claimed to be “a proud husband and father”
Mr. Costello resides in the Seattle Washington area is a proud husband and father. Mr. Costello completed his undergraduate work at University of Minnesota (Minneapolis, MN) and graduate work at Harvard University (Cambridge, MA).
Did he make that up too? Was that claim to make him look more legitimate and stable?
There are just so many little (and not so little) discrepancies with his background it pretty tough to know what’s really true.
Recent MAJI News
- NexTel Medical Corp Announces Pivotal Milestone in Commercial Launch of Patent-Protected NANOG DNA Cancer Screening Test • GlobeNewswire Inc. • 04/07/2026 02:30:00 PM
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 03/30/2026 04:15:02 AM
- Form 253G1 - • Edgar (US Regulatory) • 03/27/2026 07:12:08 PM
- Form 1-A POS - • Edgar (US Regulatory) • 03/26/2026 08:25:15 PM
- Form 1-A POS - • Edgar (US Regulatory) • 03/20/2026 08:23:33 PM
- Exousia Pro, Inc. Announces Favorable Litigation Settlement, Highlighting Significant Debt Elimination and Share Cancellation to Enhance Shareholder Value • GlobeNewswire Inc. • 03/16/2026 02:15:00 PM
- Form 1-A POS - • Edgar (US Regulatory) • 03/11/2026 07:11:39 PM
- Exousia Pro, Inc. Announces Strategic Elimination of Future Dilutive Issuance of 47 Million Shares, Progresses Toward Definitive Agreements for Telehealth Acquisitions • GlobeNewswire Inc. • 03/05/2026 06:00:20 PM
- Form 1-A POS - • Edgar (US Regulatory) • 02/19/2026 09:39:04 PM
- Form 253G2 - • Edgar (US Regulatory) • 02/11/2026 08:06:08 PM
- Exousia Pro, Inc. Accelerates Strategic Expansion with Third Telehealth Acquisition; Strengthens Pathway to Low-Cost Customer Acquisition • GlobeNewswire Inc. • 02/10/2026 03:30:00 PM
- Form 253G2 - • Edgar (US Regulatory) • 01/15/2026 06:47:01 PM
- Form 253G1 - • Edgar (US Regulatory) • 01/14/2026 09:54:45 PM
- Form 1-A POS - • Edgar (US Regulatory) • 12/31/2025 12:32:47 PM
- Form 253G2 - • Edgar (US Regulatory) • 12/29/2025 08:29:49 PM
- Exousia Pro, Inc. Announces Executed LOI for Strategic Acquisition of High-Revenue Telehealth Platform to Accelerate Nutraceutical Commercialization • ACCESS Newswire • 12/11/2025 05:15:00 PM
- Exousia Pro, Inc. Revolutionizes Nutraceuticals With Launch Of Maxasome(TM): The First All-Natural, Biologically Active Exosomal Supplement • ACCESS Newswire • 12/05/2025 04:00:00 PM
- Form 253G2 - • Edgar (US Regulatory) • 12/04/2025 09:35:28 PM
- Exousia Pro, Inc. Completes Exclusive Licensing Agreement With the University of Central Florida for Novel Cancer Diagnostic and Therapy Platforms • ACCESS Newswire • 12/02/2025 06:45:00 PM
- Exousia Pro Initiates Strategic Realignment, Acquires Controlling Stake in SEC-Reporter Lamy (LMMY) in All-stock Exchange Transaction for Exousia AI, to Advance Growth and Enhance Shareholder Value • ACCESS Newswire • 11/17/2025 08:40:00 PM
- Exousia Pro Announces Breakthrough In Exosome-Based Delivery • ACCESS Newswire • 11/04/2025 03:40:00 PM
- Exousia Pro is Excited to Announce that it has Received Orphan Drug Designation from the FDA • ACCESS Newswire • 10/28/2025 02:20:00 PM
- Exousia Pro Announces Groundbreaking Study to Revolutionize the Global Edibles Market with CBD-Loaded Exosomes • ACCESS Newswire • 09/29/2025 04:35:00 PM
- Exousia Pro Reports Positive Outcome in Legal Proceeding • ACCESS Newswire • 09/26/2025 02:30:00 PM
